Price T Rowe Associates Inc Glaukos Corp Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Glaukos Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 30,364 shares of GKOS stock, worth $3.59 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,364
Previous 313,924
90.33%
Holding current value
$3.59 Million
Previous $25 Million
88.52%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding GKOS
# of Institutions
273Shares Held
43.6MCall Options Held
89.8KPut Options Held
236K-
Black Rock Inc. New York, NY7.9MShares$935 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.31MShares$628 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.13MShares$252 Million3.61% of portfolio
-
State Street Corp Boston, MA1.83MShares$216 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.61MShares$191 Million0.09% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.63B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...